期刊文献+

脑梗死后出血性转化临床分析 被引量:9

下载PDF
导出
摘要 目的探讨脑梗死后出血性转化的临床特点、病因及诊断治疗。方法回顾分析本院120例脑梗死后出血性转化患者的临床资料。结果出血性转化多发生于起病3 d到2周,与大面积梗死、合并冠心病、心房纤颤、糖尿病、高血压等有关。本组120例患者均经头颅CT或MRI证实。经治疗后107例预后良好,9例预后较差,4例因同时并发心衰、肾衰等死亡。结论脑梗死后发生出血性转化并非都会使病情加重,早期无症状性出血性转化为脑梗死血管再通的一种表现,优于阻塞动脉血管未通者,远期预后良好。症状性出血性转化患者预后较差。
出处 《中国实用医药》 2012年第33期69-70,共2页 China Practical Medicine
  • 相关文献

参考文献8

  • 1FioreUi M,Bastianello S,von Kummer R,et al.Hemorrhngictran-sformation within 36 hours of a cerebral infarctrelationships with early clinical deterioration and 3-monthoutcome in the European Cooperative Acute Stroke StudyI(ECASS I)cohort.Stroke,1999,30(11):2280-2284.
  • 2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15747
  • 3Berger C,Fiorelli M,Steiner T,et al.Hemorrhagic transformationof ischemic brain tissue:asymptomatic or symptomatic.Stroke,2001,32:1330-1335.
  • 4Gilligan AK,Markus R,Read S,et al.Baseline blood pressurebut not early computed tomography changes predicts majorhemorrhage after streptokinase in acute ischemic stroke.Stroke,2002,33:2236-2242.
  • 5Motto C,Ciccone A,Aritze E,et al.Hemorrhage after an acuteischemic stroke.Stroke,1999,30:761-764.
  • 6Lanne V,Kummer RR Muller A,et al.Risk factors for severehemorrhagic transformation in ischemic stroke patients treated withrecombinant tissue plasminogen activator:a secondary analysis of the European Ausualasian Acute Stroke Study (EAASS II)J.Stroke,2001,32:438-441.
  • 7田成林,蒲传强,李雪梅,李正军.出血性脑梗死的危险因素及预后[J].中华老年心脑血管病杂志,2003,5(4):249-251. 被引量:43
  • 8Bourekas EC,Slivka AP,Shah R,et al.Intraarterialthrombolytic therapy within 3 hours of the onset of stroke.Neumsurgery,2004,54(1):39-44.

二级参考文献10

  • 1Molina CA,Montaner J, Abilleira S, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke[ J]. Stroke,2001,32:1079-1084.
  • 2Kidwell CS, Saver JL, Carneado J,et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis [ J ].Stroke, 2002,33:717-724.
  • 3Larrue V, von Kummer RR, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASB II) [ J]. Stroke,2001,32:438-441.
  • 4Motto C,Ciccone A,Aritzu E,et al. Hemorrhage after an acute ischemic stroke. MAST-I Collaborative Group [ J ]. Stroke, 1999, 30: 761-764.
  • 5Broderick JP, Hagen T, Brott T, et ak. Hyperglycemia and hemorrhagic transformation of cerebral infarcts[J]. Stroke, 1995,26:484-487.
  • 6Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group[J]. N Engl J Med, 1995,333:1581-1587.
  • 7Adams HP. Emergent use of anticoagulation for treatment of patients with ischemic stroke[ J ]. Stroke, 2002, 33 : 856-861.
  • 8Chen ZM,Sandercock P, Pan HC, et al. Indicatices for early aspirin use in acute ischemic stroke:a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups[J].Stroke,2000,31 : 1240-1249.
  • 9Chaves CJ, Pessin MS, Caplan LR, et al. Cerebellar hemorrhagic infarction [ J ]. Neurology, 1996,46: 346-349.
  • 10Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic[J]. Stroke, 2001,32:1330-1335.

共引文献15785

同被引文献40

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部